跳至主要内容
临床试验/NCT04253860
NCT04253860终止3 期

Effect of Transcutaneous Electrical Nerve Stimulation on Pain percepción and Serum Inflammatory Markers in Patients With Peripheral Diabetic Neuropathy

Centro Universitario de Tonalá2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年2月1日最近更新:
适应症

试验速览

阶段
3 期
状态
终止
发起方
入组人数
20
试验地点
2
主要终点
Pain perception

研究概览

简要总结

Double-blind, randomized, placebo-controlled, clinical trial. Patients with diabetic neuropathy will be randomly assigned to treatment with either TENS or TENS sham three times a week during 90 days. Clinical determinations are: pain, levesls of TNF-alpha, IL-6 and RPC-us

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnostic of type 2 diabetes > 10 years
  • Diagnostic of peripheral diabetic neuropathy less than 5 years
  • HbA1C > 6.5 and < 9%
  • Plasmatic glucose >140 mg/dL and lees than 350 mg/dL
  • Informed consent signed

排除标准

  • Use of implanted pacemaker or heart defibrillator
  • Implanted brain stimulator
  • History of alcohol abuse
  • Use of NSAID, stereoids
  • Subjects with wounds, ulcers in legs
  • Subjects with hepatic, renal o neurologic diseases

结局指标

主要结局

Pain perception

时间窗: Change from Baseline Pain perception at 90 days

Evaluation of neuropathic pain evaluated with VAS

次要结局

  • Tumoral Necrosis Factor Alpha(Change from Baseline serum levels of TNF-alpha at 90 days)
  • C Reactive Protein ultra-sensible(Change from Baseline serum levels of CRP-us at 90 days)
  • Interleukin-6(Change from Baseline serum levels of IL-6 at 90 days)

研究者

发起方
Centro Universitario de Tonalá
申办方类型
Other
责任方
Principal Investigator
主要研究者

Arieh Roldán Mercado Sesma

Investigator

Centro Universitario de Tonalá

研究点 (2)

Loading locations...

相似试验